All Clinical Trials
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
SUBQ DARATUMUMAB IN ELDERLY PATIENTSIxazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
SUBQ DARATUMUMAB IN ELDERLY PATIENTS
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials